Schizophrenia

Health

Increased risk of psychopathology found in offspring of people with schizophrenia or bipolar disorder

A new study confirms that children of people with schizophrenia or bipolar disorder have a higher risk of developing psychopathology…

Read More »
Health

LSD analogue with potential for treating schizophrenia developed

University of California, Davis researchers have developed a new, neuroplasticity-promoting drug closely related to LSD that harnesses the psychedelic’s therapeutic…

Read More »
Health

Potential risk biomarkers found for schizophrenia resulting from cannabis use

Cannabis is one of the most widely used substances in the world, with some 228 million users between the ages…

Read More »
Health

Part of the genetic risk for schizophrenia acts through the placenta

The study, which involved 28 researchers from 18 institutions across Europe and the United States, highlights the placenta as a…

Read More »
Health

Genetic risk of schizophrenia affects men and women differently

A joint research study conducted by the UAB and the UB has analysed the relation between the genetic risk of…

Read More »
Health

F.D.A. Expands Access to Clozapine, a Key Treatment for Schizophrenia

The Food and Drug Administration has taken a crucial step toward expanding access to the antipsychotic medication clozapine, the only…

Read More »
Health

Mutation increases enzyme in mouse brains linked to schizophrenia behaviors

A genetic mutation found in two human patients with schizophrenia also increased schizophrenia-related behaviors in mice with the same mutation,…

Read More »
CBD

Cannabis Use Disorder And Schizophrenia

A potential link between cannabis use and new cases of schizophrenia is in the spotlight again after a study found…

Read More »
Health

People with schizophrenia have an altered ability to visually perceive contrast

Schizophrenia is a serious mental disorder that affects around 1% of the world’s population. Researchers of the University of Barcelona…

Read More »
Money

AbbVie Takes $3.5B Impairment Charge for Failed Schizophrenia Drug

Key Takeaways AbbVie said it would take a $3.5 billion dollar impairment charge related to the failure of a drug…

Read More »
Back to top button